Amphastar Pharmaceuticals (AMPH) Share-based Compensation (2013 - 2026)

Amphastar Pharmaceuticals' Share-based Compensation history runs 14 years deep, the most recent figure standing at $9.3 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 10.5% year-over-year to $9.3 million; the TTM figure through Mar 2026 stood at $28.2 million (up 10.85% YoY), while the FY2025 annual figure was $27.3 million, up 11.94% from the prior year.
• Share-based Compensation was $9.3 million for Q1 2026 at Amphastar Pharmaceuticals, up from $6.2 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $9.3 million in Q1 2026 to a low of $4.2 million in Q2 2022.
• Historically, Share-based Compensation has averaged $5.8 million across 5 years, with a median of $5.6 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Share-based Compensation plunged 30.39% in 2022, then climbed 21.85% in 2024.
• A 5-year view of Share-based Compensation shows it stood at $4.3 million in 2022, then advanced by 7.39% to $4.6 million in 2023, then advanced by 21.85% to $5.6 million in 2024, then gained by 10.17% to $6.2 million in 2025, then surged by 49.46% to $9.3 million in 2026.
• The last three Share-based Compensation figures came in at $9.3 million (Q1 2026), $6.2 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.